검색결과 : 3건
| No. | Article |
|---|---|
| 1 |
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers Hatzivassiliou G, Haling JR, Chen HF, Song K, Price S, Heald R, Hewitt JFM, Zak M, Peck A, Orr C, Merchant M, Hoeflich KP, Chan J, Luoh SM, Anderson DJ, Ludlam MJC, Wiesmann C, Ultsch M, Friedman LS, Malek S, Belvin M Nature, 501(7466), 232, 2013 |
| 2 |
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 Wertz IE, Kusam S, Lam C, Okamoto T, Sandoval W, Anderson DJ, Helgason E, Ernst JA, Eby M, Liu JF, Belmont LD, Kaminker JS, O'Rourke KM, Pujara K, Kohli PB, Johnson AR, Chiu ML, Lill JR, Jackson PK, Fairbrother WJ, Seshagiri S, Ludlam MJC, Leong KG, Dueber EC, Maecker H, Huang DCS, Dixit VM Nature, 471(7336), 110, 2011 |
| 3 |
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 (vol 471, pg 110, 2011) Wertz IE, Kusam S, Lam C, Okamoto T, Sandoval W, Anderson DJ, Helgason E, Ernst JA, Eby M, Liu JF, Belmont LD, Kaminker JS, O'Rourke KM, Pujara K, Kohli PB, Johnson AR, Chiu ML, Lill JR, Jackson PK, Fairbrother WJ, Seshagiri S, Ludlam MJC, Leong KG, Dueber EC, Maecker H, Huang DCS, Dixit VM Nature, 475(7354), 122, 2011 |